Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/3/2026

Avoid Hydroxyzine in Older Adults Because of Significant Anticholinergic and Sedative Risks

Guideline‑Based Recommendations

  • The American Geriatrics Society (2015) explicitly recommends avoiding hydroxyzine in older adults because its potent anticholinergic properties increase the risk of delirium, cognitive impairment, and falls. 2
  • The 2008 rhinitis guidelines state that older adults are especially sensitive to psychomotor impairment from first‑generation antihistamines such as hydroxyzine, leading to a higher incidence of fractures, subdural hematomas, and other anticholinergic adverse effects. 1

Specific Risks in Older Adults

  • Anticholinergic burden: Hydroxyzine adds substantially to cumulative anticholinergic exposure, which is linked to cognitive decline and delirium in the elderly. [3][2]
  • Sedation and performance impairment: Even when taken at bedtime, hydroxyzine can cause next‑day sedation and impair driving performance—effects that may occur without the patient feeling drowsy. 1
  • Impaired driving: Use of hydroxyzine worsens driving performance, especially when combined with secondary tasks such as cell‑phone use. 1
  • Fall risk: The anticholinergic and sedating properties of hydroxyzine markedly increase the likelihood of falls and related injuries (e.g., fractures, subdural hematomas) in older adults. 1

Safer Pharmacologic Alternatives for Anxiety in Older Adults

  • Second‑generation antihistamines (e.g., fexofenadine, loratadine, desloratadine) do not produce sedation at recommended doses and are preferred when antihistaminic effects are needed. 1
  • Low‑dose short‑term benzodiazepines (e.g., lorazepam 0.25–0.5 mg) may be used only when absolutely necessary, acknowledging their own fall and cognitive risk profile. [4][5]
  • Acute anxiety or agitation:
    • Lorazepam 0.5–1 mg orally (reduce to 0.25–0.5 mg in frail elders). [4][5]
    • Haloperidol 0.5–1 mg (reduce to 0.25–0.5 mg in older/frail patients) for delirium with anxiety. [6][4]

Practical Management When Hydroxyzine Is Present

  • Deprescribing approach: In most cases, taper and discontinue hydroxyzine, transitioning to safer alternatives. (Guideline consensus)
  • If continuation is unavoidable:
    • Start with the lowest possible dose (10–25 mg).
    • Monitor closely for sedation, confusion, falls, and anticholinergic effects; reassess frequently. 7
  • Avoid “as‑needed” dosing: Intermittent use still carries significant risk because hydroxyzine’s half‑life and tissue effects persist longer than plasma levels. 1
  • Avoid polypharmacy with other sedating or anticholinergic agents: Concurrent use dramatically amplifies adverse‑event risk. 3